Ogura Asami, Izawa Kazuhiro P, Sato Shinji, Tawa Hideto, Kureha Fumie, Wada Masaaki, Kanai Masashi, Kubo Ikko, Yoshikawa Ryohei, Matsuda Yuichi
Department of Rehabilitation, Sanda City Hospital, 669-1321 Hyogo, Japan.
Department of Public Health, Graduate School of Health Sciences, Kobe University, 654-0142 Hyogo, Japan.
Rev Cardiovasc Med. 2022 May 27;23(6):191. doi: 10.31083/j.rcm2306191. eCollection 2022 Jun.
Identifying the causes of low peak oxygen uptake (peak V̇ ) in heart disease patients with renal dysfunction is necessary for prognostic improvement strategies. The purpose of this study was to verify the determinants of peak V̇ for each stage of renal function in heart disease patients, focusing on end-tidal oxygen partial pressure ( ).
Two hundred fifty heart disease patients who underwent cardiopulmonary exercise testing (CPET) in our institution were consecutively enrolled. Patients were divided into three groups by their estimated glomerular filtration rate (eGFR): 45, 45-59 and 60 mL/min/1.73 . Patient characteristics and CPET parameters including (rest-anaerobic threshold) were compared between the groups. The relationship between PETO and peak V̇ was also investigated for each group.
In total, 201 patients were analyzed. decreased with the deterioration of renal function (eGFR 45, 0.1 mmHg vs. eGFR 45-59, 2.4 mmHg vs. eGFR 60, 5.2 mmHg, 0.001). In the eGFR 45 group, left ventricular ejection fraction (LVEF) and hemoglobin (Hb) were significantly associated with peak V̇ = 0.518, 0.001 and = 0.567, 0.001, respectively), whereas was not. In the eGFR 45-59 group, age, Hb, and showed a significant association with peak V̇ ( = -0.354, = 0.006; = 0.258, = 0.007; = 0.501, 0.001; respectively). In the univariate analysis, eGFR 45-59 group showed the highest coefficient of determination of to peak V̇ ( = 0.247, 0.001).
The determinants of peak V̇ in heart disease patients depended on the stage of renal function. The determinants of peak V̇ in patients with eGFR 45 were LVEF and Hb, while was the strongest predictor of peak V̇ in patients with eGFR 45-59.
确定肾功能不全的心脏病患者峰值摄氧量(峰值V̇ )降低的原因对于改善预后策略至关重要。本研究旨在验证心脏病患者不同肾功能阶段峰值V̇ 的决定因素,重点关注呼气末氧分压( )。
连续纳入在我院接受心肺运动试验(CPET)的250例心脏病患者。根据估算的肾小球滤过率(eGFR)将患者分为三组:<45、45 - 59和≥60 mL/min/1.73 。比较各组患者的特征和CPET参数,包括 (静息无氧阈)。还研究了每组中呼气末氧分压(PETO )与峰值V̇ 之间的关系。
共分析了201例患者。随着肾功能恶化, 降低(eGFR <45时为0.1 mmHg,eGFR 45 - 59时为2.4 mmHg,eGFR≥60时为5.2 mmHg,P<0.001)。在eGFR <45组中,左心室射血分数(LVEF)和血红蛋白(Hb)与峰值V̇ 显著相关(分别为 = 0.518,P<0.001和 = 0.567,P<0.001),而 无相关性。在eGFR 45 - 59组中,年龄、Hb和 与峰值V̇ 显著相关(分别为 = -0.354,P = 0.006; = 0.258,P = 0.007; = 0.501,P<0.001)。单因素分析中,eGFR 45 - 59组中 对峰值V̇ 的决定系数最高( = 0.247,P<0.001)。
心脏病患者峰值V̇ 的决定因素取决于肾功能阶段。eGFR <45患者峰值V̇ 的决定因素是LVEF和Hb,而eGFR 45 - 59患者中 是峰值V̇ 的最强预测因素。